JMP Group LLC (NYSE: JMP), an funding banking and different asset administration agency, introduced at the moment that Fedora Baloiu has joined JMP Securities as a managing director and co-head of biopharma company finance. Moreover, Silvan Tuerkcan and Gobind Singh, a director and vp, respectively, have each joined JMP Securities as senior fairness analysis analysts centered on the biotechnology sector. All three are based mostly within the agency’s New York workplace.
In reference to these key additions to JMP Securities’ life sciences franchise, David Kellman, a managing director and head of healthcare funding banking, may also function co-head of biopharma company finance, whereas David Schechner, a managing director within the healthcare funding banking group, has been named head of biopharma mergers and acquisitions.
“We couldn’t be extra enthusiastic in regards to the latest developments in our healthcare group,” stated Mark Lehmann, chief government officer of JMP Securities. “JMP has lengthy been properly acknowledged throughout the life sciences business for its fairness analysis and funding banking capabilities, and our platform is now broader than ever earlier than. Our three latest additions might be quick contributors. Fedora brings longstanding relationships and glorious perspective on the healthcare capital markets, whereas Silvan and Gobind have already begun to enrich our current biotech analysis with preliminary protection of their very own. Because of this, we’re positioned to construct on our success, making our agency a good higher useful resource for our company and institutional shoppers within the life sciences house.”
Previous to becoming a member of JMP Securities, Ms. Baloiu was a managing director and head of U.S. healthcare funding banking at Nomura Securities. She beforehand served as head of the biopharmaceuticals follow at Houlihan Lokey, after spending practically a decade within the healthcare funding banking division at Goldman Sachs & Co. Ms. Baloiu started her profession as a advisor at Bain & Firm in Milan, Italy. She holds a grasp’s diploma in biotechnology from Johns Hopkins College, an MBA from Columbia Enterprise College, and an undergraduate enterprise diploma from Italy’s Bocconi College.
Previous to becoming a member of JMP Securities, Mr. Tuerkcan was an government director and senior analysis analyst protecting biotechnology at each UBS and Oppenheimer & Co. He beforehand labored in fairness analysis at Goldman Sachs & Co. Mr. Tuerkcan started his profession as a postdoctoral fellow each at Institut Pasteur & Ecole Polytechnique in France and later on the Stanford College College of Drugs. He holds a PhD in biophysics from France’s Ecole Polytechnique, an MSc in engineering physics from Germany’s TU Munich, and a BSc in physics from Canada’s McGill College.
Previous to becoming a member of JMP Securities, Mr. Singh labored in fairness analysis at BMO Capital Markets, with a deal with the biotechnology sector. Earlier than beginning his monetary companies profession, Mr. Singh engaged in medical follow and tutorial analysis whereas a doctor at nationally acknowledged medical facilities akin to UCSF. He holds MD and PhD levels from Mount Sinai College of Drugs and an undergraduate diploma with concentrations in chemistry, biochemistry, and biology from Boston College.
JMP Securities is a full-service, middle-market funding financial institution with a healthcare follow consisting of 5 senior funding bankers, a devoted senior capital markets skilled, and 7 fairness analysis analysts protecting biotechnology, biopharmaceuticals, and medical gadgets and provides. The agency’s healthcare funding banking group executed 51 capital elevating and strategic advisory transactions with an mixture worth of $6.1 billion in 2020.
About JMP Group
JMP Group LLC is a diversified capital markets agency that gives funding banking, fairness analysis, and gross sales and buying and selling companies to company and institutional shoppers in addition to different asset administration services to institutional and high-net-worth traders. JMP Group conducts its funding banking and analysis, gross sales, and buying and selling actions via JMP Securities; its enterprise capital and personal capital actions via Harvest Capital Methods and JMP Asset Administration; and the administration of Harvest Capital Credit score Company (NASDAQ: HCAP), a enterprise growth firm, via HCAP Advisors. For extra info, go to [url=”]www.jmpg.com[/url].
View supply model on businesswire.com: https://www.businesswire.com/news/home/20210125005717/en/